Sidney Kimmel Comprehensive Cancer At Johns Hopkins is a clinical research site located in Baltimore, Maryland, United States 21287.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Sidney Kimmel Comprehensive Cancer At Johns Hopkins has participated in 5 clinical trials with 4 currently active.
Therapeutic areas: Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Relapsed Chronic Lymphocytic Leukemia.
Sponsors: BeOne Medicines, BeiGene, Opna Bio LLC.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Sidney Kimmel Comprehensive Cancer At Johns Hopkins has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sidney Kimmel Comprehensive Cancer At Johns Hopkins has 5 clinical trials on record, with 4 currently active. Their work covers Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Relapsed Chronic Lymphocytic Leukemia.
Yes — Sidney Kimmel Comprehensive Cancer At Johns Hopkins holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.